TABLE 1
FROM:
Newborn Blood Spot Screening in Four Countries: Stakeholder Involvement
Beth K Potter, Denise Avard and Brenda J Wilson
BACK TO ARTICLETable 1. Organizations whose policy-relevant literature was included in our review
| National-level governmental organizations |
| UK: National Screening Committee, Newborn Screening Programme Centre |
| US: Centers for Disease Control and Prevention, Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children |
| Australia: Law Reform Commission & Health Ethics Committee (commissioned inquiry) |
| Canada: no national-level governmental policy documents were identified |
| Professional physician associations |
| UK: Clinical Genetics Society |
| US: American College of Medical Genetics, American Academy of Pediatrics |
| Australia: Human Genetics Society of Australia, Royal Australasian College of Physicians |
| Canada: Canadian College of Medical Geneticists, Canadian Paediatric Society |
| Consumer or patient associations |
| UK: Genetic Interest Group, Cystic Fibrosis Trust |
| US: Genetic Alliance, March of Dimes, Cystic Fibrosis Foundation |
| Australia: Association of Genetic Support of Australasia |
| Canada: Canadian Cystic Fibrosis Foundation, Canadian Organization for Rare Disorders |
